PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.
<h4>Background</h4>Liver-related deaths represent the leading cause of mortality among patients with HIV/HCV-co-infection, and are mainly related to complications of fibrosis and portal hypertension. In this study, we aimed to evaluate the structural changes by the assessment of extracel...
Enregistré dans:
Auteurs principaux: | Christian Jansen, Diana J Leeming, Mattias Mandorfer, Inger Byrjalsen, Robert Schierwagen, Philipp Schwabl, Morten A Karsdal, Evrim Anadol, Christian P Strassburg, Jürgen Rockstroh, Markus Peck-Radosavljevic, Søren Møller, Flemming Bendtsen, Aleksander Krag, Thomas Reiberger, Jonel Trebicka |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5ccb18101b9e4197bd1a89a1c67ebc58 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The role of miRNA-34a as a prognostic biomarker for cirrhotic patients with portal hypertension receiving TIPS.
par: Christian Jansen, et autres
Publié: (2014) -
Soluble TNF-alpha-receptors I are prognostic markers in TIPS-treated patients with cirrhosis and portal hypertension.
par: Jonel Trebicka, et autres
Publié: (2013) -
Role of circulating angiogenin levels in portal hypertension and TIPS.
par: Alexander Queck, et autres
Publié: (2021) -
Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
par: Mattias Mandorfer, et autres
Publié: (2014) -
The Utility of ANTI-HCV S/CO Ratio, HCV-RNA and ALT Test in Predicting Viremia in ANTI-HCV Positive Patients
par: Tuğrul Himmetoğlu, et autres
Publié: (2007)